Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Synapsins × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Specimen Handling 251 pembrolizumab 244 Magnetic Resonance Spectroscopy 239 Cyclophosphamide 210 Radiotherapy 186 Nivolumab 149 Biopsy 142 Carboplatin 124 venetoclax 116 Cisplatin 116 fludarabine 114 Standard of Care 109 Radiosurgery 104 Dexamethasone 104 Surveys and Questionnaires 99 Paclitaxel 95 Blood Specimen Collection 94 Drug Therapy 92 Gemcitabine 83 Radiation 77 Oxaliplatin 77 Bevacizumab 77 Rituximab 75 Ipilimumab 73 Fluorouracil 69 durvalumab 68 Temozolomide 66 Cytarabine 65 Capecitabine 65 Interviews as Topic 64

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡